In a first, drug using 3D printing technology gets FDA nod

Customised: 3D printing tech could pave the way to drugs and products that are specifically tailored to each individual patient's needs, say analysts. Photo: AFP Relaxnews

The US Food and Drug Administration has, for the first time, approved a drug that uses 3D printing technology, paving the way for potential customisation of drugs to suit patients' needs. 

The drug, made by privately held Aprecia Pharmaceuticals Co, was approved for oral use as a prescription adjunctive therapy in the treatment of epilepsy, the company said.